Ticker LaunchReverse merger · Completed · ACET
Adicet Bio, Inc.
Reverse merger with resTORbio, Inc. (TORC)
Adicet Bio, Inc. merged into resTORbio, Inc. (TORC), a Nasdaq-listed clinical-stage biotech, in a reverse merger that takes the private company public. The deal was announced on Apr 29, 2020 and closed on Sep 15, 2020. The combined company trades as Adicet Bio, Inc. (ACET) on Nasdaq.
Adicet Bio develops allogeneic gamma delta T cell therapies. Its lead asset ADI-001 is an off-the-shelf CAR-T cell therapy targeting CD20 for non-Hodgkin lymphoma, alongside a pipeline of other gamma delta cell therapies and antibody platforms.
- Status
- Completed
- Private company
- Adicet Bio, Inc.
- Public company
- resTORbio, Inc. (TORC)
- Public company business before
- Nasdaq-listed clinical-stage biotech
- Announced
- Apr 29, 2020
- Closed
- Sep 15, 2020
- Combined company
- Adicet Bio, Inc. (ACET)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Sep 16, 2020
- Announcement press release
- All filings on EDGAR CIK 1720580
Other completed reverse mergers
- Unique Logistics Holdings, Inc.into Innocap, Inc. · Oct 8, 2020
- Chinook Therapeutics U.S. Inc.into Aduro Biotech, Inc. · Oct 5, 2020
- Augmedix, Inc.into Malo Holdings Corporation · Oct 5, 2020
- Guskin Gold Corporationinto Inspired Builders, Inc. · Sep 24, 2020
- R3 Score Technologies, Inc.into Global Boatworks Holdings, Inc. · Sep 23, 2020
- Mosaic ImmunoEngineering Inc.into Patriot Scientific Corporation · Aug 25, 2020